PT  - JOURNAL ARTICLE
AU  - Jagadish Thaker
TI  - The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention
AID  - 10.1101/2020.12.16.20248139
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.16.20248139
4099  - http://medrxiv.org/content/early/2020/12/18/2020.12.16.20248139.short
4100  - http://medrxiv.org/content/early/2020/12/18/2020.12.16.20248139.full
AB  - Building public trust and willingness to vaccinate against COVID-19 is as important as developing an effective vaccine. However, a significant minority of the public are unwilling or hesitant to take a COVID-19 vaccine, when available. A nationally representative sample survey (N=1040) was conducted in July 2020 in New Zealand to identify factors associated with COVID-19 vaccine intention. Trust in experts and general vaccine hesitancy were significantly associated with COVID-19 vaccine intention. A communication campaign from trusted scientific experts, with information that addresses prevailing concerns about vaccines, is likely to help increase COVID-19 vaccine uptake.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMassey University provided funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval to conduct the survey was received from the Massey University Human Ethics Committee (Ethics Notification Number: 4000022852 by Professor Craig Johnson, Chair, Human Ethics Chairs' Committee and Director, Research Ethics).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available after peer-reviewed publication